CLINICAL_TRIALS
withdrawal
· 2025-06-05
Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis
Summary
A pilot study investigating the role of gut flora in Multiple Sclerosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ProgenaBiome | Conditions: Multiple Sclerosis, MS | Status: WITHDRAWN